Lazertinib
CAS: 1903008-80-9
Ref. 3D-DBD00880
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Product Information
Lazertinib is a potent tyrosine kinase inhibitor with inhibitory properties against cancer cells. Lazertinib has been shown to have inhibitory effects on epidermal growth factor receptor (EGFR) and HER2/neu receptors, which are important for the growth of solid tumours. This drug inhibits the phosphorylation of these receptors, thereby blocking their downstream signalling pathways that promote cancer cell proliferation. Lazertinib also inhibits the activity of other tyrosine kinases including c-MET, AXL and RET, which may be important for inhibiting cancer cell growth in patients with autoimmune diseases.
Chemical properties
Technical inquiry about: 3D-DBD00880 Lazertinib
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
